Plaque progression and regression in atherothrombosis
- 1 July 2007
- journal article
- review article
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 5 (s1) , 292-299
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- The Failure of TorcetrapibArteriosclerosis, Thrombosis, and Vascular Biology, 2007
- Haptoglobin Genotype Is a Determinant of Iron, Lipid Peroxidation, and Macrophage Accumulation in the Atherosclerotic PlaqueArteriosclerosis, Thrombosis, and Vascular Biology, 2007
- Pharmacology of thienopyridines: rationale for dual pathway inhibitionEuropean Heart Journal Supplements, 2006
- From Vulnerable Plaque to Vulnerable Patient—Part III: Executive Summary of the Screening for Heart Attack Prevention and Education (SHAPE) Task Force ReportThe American Journal of Cardiology, 2006
- BAY 59-7939: an oral, direct Factor Xa inhibitor for the prevention of venous thromboembolism in patients after total knee replacement. A phase II dose-ranging studyJournal of Thrombosis and Haemostasis, 2005
- Does shear stress modulate both plaque progression and regression in the thoracic aorta?JACC, 2005
- A new oral direct thrombin inhibitor, dabigatran etexilate, compared with enoxaparin for prevention of thromboembolic events following total hip or knee replacement: the BISTRO II randomized trialJournal of Thrombosis and Haemostasis, 2005
- Antitrombinas orales y predicciones para el futuro antitrombóticoRevista Espanola de Cardiologia, 2004
- Measurement of Arterial Wall Thickness as a Surrogate Marker for AtherosclerosisCirculation, 2004
- Lipid Lowering by Simvastatin Induces Regression of Human Atherosclerotic LesionsCirculation, 2002